Paul PremackA new 2023 law, the federal Inflation Reduction Act, has for the first time given legal authority for Medicare to participate in the free market by negotiating directly with drug manufacturers. The goal is to dramatically lower your out-of-pocket spending for drugs covered by Medicare Part B and Part D.
As part of that process, the Centers for Medicare & Medicaid Services announced a series of listening sessions as part of the Medicare Drug Price Negotiation Program.
